Page 17 - சர்வதேச இதழ் ஆஃப் மூலக்கூறு அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time Simple blood test could replace surgery for some brain tumour patients A research breakthrough shows that a simple blood test could reduce, or in some cases replace, the need for intrusive surgery when determining the best course of treatment for patients with a specific type of brain tumour. Researchers at the Brain Tumour Research Centre of Excellence at the University of Plymouth have discovered a biomarker which helps to distinguish whether meningioma – the most common form of adult primary brain tumour – is grade I or grade II. The grading is significant because lower grade tumours can sometimes remain dormant for long periods, not requiring high risk surgery or harsh treatments such as radiotherapy and chemotherapy. Tumours classified as grade II can progress to become cancerous and more aggressive treatment may be needed in order to try to control their spread.

United kingdomOliver hanemannHugh adamsPlymouth centre of excellenceInternational journal of molecular sciencesBrain tumour researchBrain tumour research centres of excellenceBrain tumour research centre of excellenceUniversity of plymouthBrain tumour research centreProfessor oliver hanemannInternational journalBrain tumour research centresTumour research centreTumour researchLiquid biopsy